The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial

被引:0
作者
Zahra Yari
Mina Movahedian
Hossein Imani
Seyed Moayed Alavian
Mehdi Hedayati
Azita Hekmatdoost
机构
[1] Shahid Beheshti University of Medical Sciences,Student Research Committee, Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute
[2] Shahid Beheshti University of Medical Sciences,Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology, Research Institute
[3] Tehran University of Medical Sciences (TUMS),Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics
[4] Middle East Liver Diseases (MELD) Center,Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences
[5] Shahid Beheshti University of Medical Sciences,undefined
来源
European Journal of Nutrition | 2020年 / 59卷
关键词
Metabolic syndrome; Hesperidin; Metabolic abnormalities; Inflammatory biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2569 / 2577
页数:8
相关论文
共 353 条
[1]  
Cornier M-A(2008)The metabolic syndrome Endocr Rev 29 777-822
[2]  
Dabelea D(2005)Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28 1769-1778
[3]  
Hernandez TL(2008)Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 27-38
[4]  
Lindstrom RC(2009)Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study Cardiovasc Diabetol 8 52-1076
[5]  
Steig AJ(2018)Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella heart study Sci Rep 8 11529-126
[6]  
Stob NR(2004)Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women Arch Intern Med 164 1066-3421
[7]  
Van Pelt RE(2001)Central role of the adipocyte in the metabolic syndrome J Investig Med 49 119-1781
[8]  
Wang H(2002)Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Circulation 106 3143-2094
[9]  
Eckel RH(2002)Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 3143-422
[10]  
Ford ES(2004)Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity Diabetes 53 1773-1173